Top Markets
Coin of the day
Algernon Pharmaceuticals Inc. Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

AGN
주식 순위 #38375
Algernon Pharmaceuticals Inc. is a clinical-stage pharmaceutical company... Algernon Pharmaceuticals Inc. is a clinical-stage pharmaceutical company dedicated to discovering and developing new treatments. Their research and development efforts concentrate on a range of serious conditions, including non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19, operating across Canada and Australia. The company's primary drug candidate, NP-120, acts as an N-methyl-d-aspartate (NMDA) receptor glutamate antagonist. This compound specifically targets the NMDA-type subunit 2B (Glu2NB) and also demonstrates agonist activity for the Sigma-1 receptor, a chaperone protein elevated during endoplasmic reticulum stress. Furthermore, Algernon is advancing AP-188, a psychedelic agent from the tryptamine family, for treating ischemic stroke in humans. Preclinical investigations for AP-188, as part of their stroke clinical research program, are underway through a collaboration with Charles River Laboratories. Established in 2015, Algernon Pharmaceuticals Inc. is headquartered in Vancouver, Canada.
주가
$0.29357476
마지막 동기화: 2026-05-14
시가총액
$1.02M
변동 (1일)
1.27%
변동 (1년)
-42.07%
국가
CA
거래 Algernon Pharmaceuticals Inc. (AGN)

카테고리

Algernon Pharmaceuticals Inc. (AGN)의 주가 이력
최고 종가: $0.29 (2026-05-01 기준)

최저 종가: $169.74 (2016-02-01 기준)
Algernon Pharmaceuticals Inc.의 주가 이력 (2016 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -22.61%
2025 16.84%
2024 -12.82%
2023 -88.01%
2022 -47.29%
2021 -85.85%
2020 524.96%
2019 -58.71%
2018 -64.50%
2017 5.94%
2016 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$505.24 29.45%
US
$846.09 29.68%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE